Novogaia
PrivateLast Round
Seed
Jan 1, 2026
Momentum Score
50 /100
Company Overview
Novogaia is a biotechnology company that develops new medicines from fungi using artificial intelligence to decode drug-like molecular structures.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, ML Platforms
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Novogaia Comps
Public and private peers based on sector, stage, and business model.
Novogaia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 1, 2026 |
Novogaia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Backed VC | Seed |
| Entrepreneurs First | Accelerator, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
Raised a seed round with Backed VC and Entrepreneurs First.
- Oct 3, 2024
Monthly visitors increased 525% MoM, reaching 394.
Novogaia Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Novogaia's valuation, stock price, and market status.
